Jessica M Duda1, Amelia D Moser1, Chun S Zuo2,3, Fei Du2,3,4, Xi Chen2,3,4, Sarah Perlo1, Christine E Richards1, Nara Nascimento1, Maria Ironside1,3, David J Crowley1, Laura M Holsen3,5,6, Madhusmita Misra3,7, James I Hudson3,8, Jill M Goldstein3,9,10, Diego A Pizzagalli1,2,3. 1. Center for Depression, Anxiety and Stress Research, McLean Hospital, Belmont, Massachusetts, USA. 2. McLean Imaging Center, McLean Hospital, Belmont, Massachusetts, USA. 3. Harvard Medical School, Boston, Massachusetts, USA. 4. Schizophrenia and Bipolar Research Program, McLean Hospital, Belmont, Massachusetts, USA. 5. Department of Medicine, Division of Women's Health, Brigham & Women's Hospital, Boston, Massachusetts, USA. 6. Department of Psychiatry, Brigham & Women's Hospital, Boston, Massachusetts, USA. 7. Department of Pediatrics, Division of Pediatric Endocrinology, Massachusetts General Hospital, Boston, Massachusetts, USA. 8. Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts, USA. 9. Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA. 10. Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Abstract
PURPOSE: Gamma-aminobutyric acid (GABA) abnormalities have been implicated in a range of neuropsychiatric disorders. Despite substantial interest in probing GABA in vivo, human imaging studies relying on magnetic resonance spectroscopy (MRS) have generally been hindered by technical challenges, including GABA's relatively low concentration and spectral overlap with other metabolites. Although past studies have shown moderate-to-strong test-retest repeatability and reliability of GABA within certain brain regions, many of these studies have been limited by small sample sizes. METHODS: GABA+ (macromolecular-contaminated) test-retest reliability and repeatability were assessed via a Meshcher-Garwood point resolved spectroscopy (MEGA-PRESS) MRS sequence in the rostral anterior cingulate cortex (rACC; n = 21) and dorsolateral prefrontal cortex (dlPFC; n = 20) in healthy young adults. Data were collected on a 3T scanner (Siemens Prisma, Siemens Healthcare, Erlangen, Germany) and GABA+ results were reported in reference to both total creatine (GABA+/tCr) and water (GABA+/water). RESULTS: Results showed strong test-retest repeatability (mean GABA+/tCr coefficient of variation [CV] = 4.6%; mean GABA+/water CV = 4.0%) and reliability (GABA+/tCr intraclass correlation coefficient [ICC] = 0.77; GABA+/water ICC = 0.87) in the dlPFC. The rACC showed acceptable (but comparatively lower) repeatability (mean GABA+/tCr CV = 8.0%; mean GABA+/water CV = 7.5%), yet low-moderate reliability (GABA+/tCr ICC = 0.40; GABA+/water ICC = 0.44). CONCLUSION: The present study found excellent GABA+ MRS repeatability and reliability in the dlPFC. The rACC showed inferior results, possibly because of a combination of shimming impedance and measurement error. These data suggest that MEGA-PRESS can be utilized to reliably distinguish participants based on dlPFC GABA+ levels, whereas the mixed results in the rACC merit further investigation.
PURPOSE: Gamma-aminobutyric acid (GABA) abnormalities have been implicated in a range of neuropsychiatric disorders. Despite substantial interest in probing GABA in vivo, human imaging studies relying on magnetic resonance spectroscopy (MRS) have generally been hindered by technical challenges, including GABA's relatively low concentration and spectral overlap with other metabolites. Although past studies have shown moderate-to-strong test-retest repeatability and reliability of GABA within certain brain regions, many of these studies have been limited by small sample sizes. METHODS: GABA+ (macromolecular-contaminated) test-retest reliability and repeatability were assessed via a Meshcher-Garwood point resolved spectroscopy (MEGA-PRESS) MRS sequence in the rostral anterior cingulate cortex (rACC; n = 21) and dorsolateral prefrontal cortex (dlPFC; n = 20) in healthy young adults. Data were collected on a 3T scanner (Siemens Prisma, Siemens Healthcare, Erlangen, Germany) and GABA+ results were reported in reference to both total creatine (GABA+/tCr) and water (GABA+/water). RESULTS: Results showed strong test-retest repeatability (mean GABA+/tCr coefficient of variation [CV] = 4.6%; mean GABA+/water CV = 4.0%) and reliability (GABA+/tCr intraclass correlation coefficient [ICC] = 0.77; GABA+/water ICC = 0.87) in the dlPFC. The rACC showed acceptable (but comparatively lower) repeatability (mean GABA+/tCr CV = 8.0%; mean GABA+/water CV = 7.5%), yet low-moderate reliability (GABA+/tCr ICC = 0.40; GABA+/water ICC = 0.44). CONCLUSION: The present study found excellent GABA+ MRS repeatability and reliability in the dlPFC. The rACC showed inferior results, possibly because of a combination of shimming impedance and measurement error. These data suggest that MEGA-PRESS can be utilized to reliably distinguish participants based on dlPFC GABA+ levels, whereas the mixed results in the rACC merit further investigation.
Authors: Mark Mikkelsen; Peter B Barker; Pallab K Bhattacharyya; Maiken K Brix; Pieter F Buur; Kim M Cecil; Kimberly L Chan; David Y-T Chen; Alexander R Craven; Koen Cuypers; Michael Dacko; Niall W Duncan; Ulrike Dydak; David A Edmondson; Gabriele Ende; Lars Ersland; Fei Gao; Ian Greenhouse; Ashley D Harris; Naying He; Stefanie Heba; Nigel Hoggard; Tun-Wei Hsu; Jacobus F A Jansen; Alayar Kangarlu; Thomas Lange; R Marc Lebel; Yan Li; Chien-Yuan E Lin; Jy-Kang Liou; Jiing-Feng Lirng; Feng Liu; Ruoyun Ma; Celine Maes; Marta Moreno-Ortega; Scott O Murray; Sean Noah; Ralph Noeske; Michael D Noseworthy; Georg Oeltzschner; James J Prisciandaro; Nicolaas A J Puts; Timothy P L Roberts; Markus Sack; Napapon Sailasuta; Muhammad G Saleh; Michael-Paul Schallmo; Nicholas Simard; Stephan P Swinnen; Martin Tegenthoff; Peter Truong; Guangbin Wang; Iain D Wilkinson; Hans-Jörg Wittsack; Hongmin Xu; Fuhua Yan; Chencheng Zhang; Vadim Zipunnikov; Helge J Zöllner; Richard A E Edden Journal: Neuroimage Date: 2017-07-14 Impact factor: 6.556
Authors: Marisa M Silveri; Julia Cohen-Gilbert; David J Crowley; Isabelle M Rosso; J Eric Jensen; Jennifer T Sneider Journal: Alcohol Clin Exp Res Date: 2014-02-11 Impact factor: 3.455
Authors: Christoph Abé; Anderson Mon; Timothy C Durazzo; David L Pennington; Thomas P Schmidt; Dieter J Meyerhoff Journal: Drug Alcohol Depend Date: 2012-10-30 Impact factor: 4.492
Authors: Isabelle M Rosso; Marisa M Silveri; Elizabeth A Olson; J Eric Jensen; Boyu Ren Journal: Neuropsychopharmacology Date: 2021-10-21 Impact factor: 8.294
Authors: Alexander R Craven; Pallab K Bhattacharyya; William T Clarke; Ulrike Dydak; Richard A E Edden; Lars Ersland; Pravat K Mandal; Mark Mikkelsen; James B Murdoch; Jamie Near; Reuben Rideaux; Deepika Shukla; Min Wang; Martin Wilson; Helge J Zöllner; Kenneth Hugdahl; Georg Oeltzschner Journal: NMR Biomed Date: 2022-02-23 Impact factor: 4.478
Authors: Jill M Goldstein; Diego A Pizzagalli; Maria Ironside; Amelia D Moser; Laura M Holsen; Chun S Zuo; Fei Du; Sarah Perlo; Christine E Richards; Jessica M Duda; Xi Chen; Lisa D Nickerson; Kaylee E Null; Nara Nascimento; David J Crowley; Madhusmita Misra Journal: Neuropsychopharmacology Date: 2021-08-06 Impact factor: 7.853